Salah Faaez Abdulnabi * 
1, Mostafa Mohammadi2 , Ali Jabbari3 , Omid Nikpayam4 , Somayeh Ghorbani Gholiabad5 , Hamed Abedalnabi Flaifel6 , Sarah Ali Alatter7
1, Mostafa Mohammadi2 , Ali Jabbari3 , Omid Nikpayam4 , Somayeh Ghorbani Gholiabad5 , Hamed Abedalnabi Flaifel6 , Sarah Ali Alatter7
1- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran ; Department of Anesthesia Technologies, Alfarqadein University College, Basra, Iraq , alnajmsalah63@gmail.com
2- Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
3- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4- Department of Nutrition, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
5- Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran
6- Department of Anesthesia Technologies, Alfarqadein University College, Basra, Iraq
7- Department of Obstetrics and Gynecology, Basra Teaching Hospital, Basra, Iraq
2- Department of Anesthesiology and Intensive Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
3- Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan, Iran
4- Department of Nutrition, School of Health, Golestan University of Medical Sciences, Gorgan, Iran
5- Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran
6- Department of Anesthesia Technologies, Alfarqadein University College, Basra, Iraq
7- Department of Obstetrics and Gynecology, Basra Teaching Hospital, Basra, Iraq
Abstract: (55 Views)
Background: Diabetes mellitus (DM) is a major challenge for public health worldwide. Pre-existing diabetes and gestational diabetes (GDM) are linked to poor outcomes in pregnancy, perinatal and maternal. Research indicates that GDM has become significantly more prevalent in several countries, increasing by over 30%. Glycemic control in women during pregnancy plays a major role in the health status of the mother and fetus. Macrosomia is one of the most critical adverse outcomes of DM, which results in negative consequences for the health of infants. This systematic review and meta-analysis study aimed to investigate the association between pregnancy diabetes and macrosomia in infants.
Methods: A comprehensive systematic search was conducted in electronic databases, from inception up to August 2024 to obtain related studies. Two independent researchers evaluated the studies based on the objectives of the study. The pooled effect size was computed using pooled odds risks (ORs) with 95% confidence intervals (CIs). Additionally, we conducted publication bias assessments, sensitivity analyses, and subgroup analyses. The statistical analysis incorporated twelve studies. Quality assessment of included studies was conducted using the Newcastle-Ottawa Scale (NOS).
Results: Statistical analysis in the present study on the pregnant diabetic mother and infants with macrosomia demonstrated a direct significant association between DM and macrosomia (OR: 2.94, 95% CI: 2.06-4.20, P <0.0001) and (OR: 8.17, 95% CI: 4.85-13.75, P<0.0001), respectively. Sub-group analysis revealed subjects with pre-gestational diabetes against GDM, had a greater risk of delivering an infant with macrosomia.
Conclusion: The results revealed a significant association between all three types of GDM. All three types of diabetes can lead to macrosomia, but pre-gestational diabetes has a more significant positive relationship with macrosomia. However, improving lifestyle can be considered as key strategy against macrosomia and associated diabetic complications.
Methods: A comprehensive systematic search was conducted in electronic databases, from inception up to August 2024 to obtain related studies. Two independent researchers evaluated the studies based on the objectives of the study. The pooled effect size was computed using pooled odds risks (ORs) with 95% confidence intervals (CIs). Additionally, we conducted publication bias assessments, sensitivity analyses, and subgroup analyses. The statistical analysis incorporated twelve studies. Quality assessment of included studies was conducted using the Newcastle-Ottawa Scale (NOS).
Results: Statistical analysis in the present study on the pregnant diabetic mother and infants with macrosomia demonstrated a direct significant association between DM and macrosomia (OR: 2.94, 95% CI: 2.06-4.20, P <0.0001) and (OR: 8.17, 95% CI: 4.85-13.75, P<0.0001), respectively. Sub-group analysis revealed subjects with pre-gestational diabetes against GDM, had a greater risk of delivering an infant with macrosomia.
Conclusion: The results revealed a significant association between all three types of GDM. All three types of diabetes can lead to macrosomia, but pre-gestational diabetes has a more significant positive relationship with macrosomia. However, improving lifestyle can be considered as key strategy against macrosomia and associated diabetic complications.
Keywords: Pregnancy, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetes Mellitus, Fetal Macrosomia
Article Type: Review |
Subject:
Obstetrics and Gynecology
References
1. Blair M. Diabetes mellitus review. Urol Nurs. 2016;36(1):27-36. [View at Publisher] [DOI] [PMID] [Google Scholar]
2. Kumar R, Saha P, Kumar Y, Sahana S, Dubey A, Prakash O. A review on diabetes mellitus: type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences. 2020;9(10):838-50. [View at Publisher] [DOI] [Google Scholar]
3. Hossain MJ, Al‐Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: Early detection should be focused. Health Sci Rep. 2024;7(3):e2004. [View at Publisher] [DOI] [PMID] [Google Scholar]
4. Lee I-M, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219-29. [View at Publisher] [DOI] [PMID] [Google Scholar]
5. Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1.9 million individuals from 38 observational studies. Diabetes care. 2015;38(9):1804-12. [View at Publisher] [DOI] [PMID] [Google Scholar]
6. Akter S, Goto A, Mizoue T. Smoking and the risk of type 2 diabetes in Japan: a systematic review and meta-analysis. J Epidemiol. 2017;27(12):553-61. [View at Publisher] [DOI] [PMID] [Google Scholar]
7. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2· 7 million participants. Lancet. 2011;378(9785):31-40. [View at Publisher] [DOI] [PMID] [Google Scholar]
8. Cornier MA, Donahoo WT, Pereira R, Gurevich I, Westergren R, Enerback S, et al. Insulin sensitivity determines the effectiveness of dietary macronutrient composition on weight loss in obese women. Obes Res. 2005;13(4):703-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
9. Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015;2015(1):508409. [View at Publisher] [DOI] [PMID] [Google Scholar]
10. Maj M, Ilhan A, Neziri D, Gartner W, Berggard T, Attems J, et al. Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology. World J Diabetes. 2011;2(4):49-53. [View at Publisher] [DOI] [PMID] [Google Scholar]
11. Schulze MB, Hoffmann K, Manson JE, Willett WC, Meigs JB, Weikert C, et al. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005;82(3):675-84. [View at Publisher] [DOI] [PMID] [Google Scholar]
12. Kc K, Shakya S, Zhang H. Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab. 2015;66(Suppl 2):14-20. [View at Publisher] [DOI] [PMID] [Google Scholar]
13. Alia S, Pugnaloni S, Borroni F, Mazzanti L, Giannubilo SR, Ciavattini A, et al. Impact of gestational diabetes mellitus in maternal and fetal health: An update. Diabetes Updates. 2019;5(3):1-6. [View at Publisher] [DOI] [Google Scholar]
14. Zamorski MA, Biggs WS. Management of suspected fetal macrosomia. Am Fam Physician. 2001;63(2):302-6. [View at Publisher] [PMID] [Google Scholar]
15. Wang Y-W, Chen Y, Zhang Y-J. Risk factors combine in a complex manner in assessment for macrosomia. BMC Public Health. 2023;23(1):271. [View at Publisher] [DOI] [PMID] [Google Scholar]
16. Salihu HM, Dongarwar D, King LM, Yusuf KK, Ibrahimi S, Salinas-Miranda AA. Trends in the incidence of fetal macrosomia and its phenotypes in the United States, 1971-2017. Arch Gynecol Obstet. 2020;301:415-26. [View at Publisher] [DOI] [PMID] [Google Scholar]
17. Mou SS, Gillies C, Hu J, Danielli M, Al Wattar BH, Khunti K, et al. Association between HbA1c levels and fetal macrosomia and large for gestational age babies in women with gestational diabetes mellitus: a systematic review and meta-analysis of 17,711 Women. J Clin Med. 2023;12(11):3852. [View at Publisher] [DOI] [PMID] [Google Scholar]
18. Capobianco G, Gulotta A, Tupponi G, Dessole F, Pola M, Virdis G, et al. Materno-fetal and neonatal complications of diabetes in pregnancy: a retrospective study. J Clin Med. 2020;9(9):2707. [View at Publisher] [DOI] [PMID] [Google Scholar]
19. Saleh A, Al-Mendalawi M. Fetal macrosomia greater than or equal to 4000 grams. Comparing maternal and neonatal outcomes in diabetic and non-diabetic women. Saudi Med J. 2009;30(4):583. [View at Publisher] [Google Scholar]
20. Cruz J, Grandía R, Padilla L, Rodríguez S, Hernández P, Lang J, et al. Macrosomia predictors in infants born to Cuban mothers with gestational diabetes. MEDICC Rev. 2015;17(3):27-32. [View at Publisher] [DOI] [PMID] [Google Scholar]
21. Isaku M, Vrapi E, Cala I, Perdja K, Bimbashi A. Macrosomia risk factors and perinatal outcomes: a 1-year cohort study. Open Access Macedonian Journal of Medical Sciences. 2023;11(B):162-5. [View at Publisher] [DOI] [Google Scholar]
22. Lewandowska M. The role of maternal weight in the hierarchy of macrosomia predictors; overall effect of analysis of three prediction indicators. Nutrients. 2021;13(3):801. [View at Publisher] [DOI] [PMID] [Google Scholar]
23. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group* t. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
24. Chandler J, Cumpston M, Li T, Page MJ, Welch V. Cochrane handbook for systematic reviews of interventions. Hoboken:Wiley;2019. [View at Publisher] [Google Scholar]
25. Ma X, Yu H. Cancer issue: global burden of cancer. Yale J Biol Med. 2006;79(3-4):85-94. [View at Publisher] [Google Scholar]
26. Bawah AT, Ngala RA, Alidu H, Seini MM, Wumbee JDK, Yeboah FA. Gestational diabetes mellitus and obstetric outcomes in a Ghanaian community. Pan Afr Med J. 2019;32(1):94. [View at Publisher] [DOI] [PMID] [Google Scholar]
27. Saleh AM, Al-Sultan SM, Moria AM, Rakaf FI, Turkistani YM, Al-Onazi SH. Fetal macrosomia greater than or equal to 4000 grams Comparing maternal and neonatal outcomes in diabetic and nondiabetic women. Saudi Med J. 2008;29(10):1463-9. [View at Publisher] [Google Scholar]
28. Timur BB, Timur H, Tokmak A, Isik H, Eyi EGY. The influence of maternal obesity on pregnancy complications and neonatal outcomes in diabetic and nondiabetic women. Geburtshilfe und Frauenheilkunde. 2018;78(04):400-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
29. Bhat M, Ramesha K, Sarma SP, Menon S, Kumar SG. Outcome of gestational diabetes mellitus from a tertiary referral Center in South India: a case-control study. J Obstet Gynaecol India. 2012;62(6):644-9. [View at Publisher] [DOI] [PMID] [Google Scholar]
30. Wang N, Song L, Sun B, Peng Y, Fei S, Cui J, et al. Contribution of gestational diabetes mellitus heterogeneity and prepregnancy body mass index to large‐for‐gestational‐age infants-A retrospective case‐control study. J Diabetes. 2021;13(4):307-17. [View at Publisher] [DOI] [PMID] [Google Scholar]
31. Du J, Zhang X, Chai S, Zhao X, Sun J, Yuan N, et al. Nomogram-based risk prediction of macrosomia: a case-control study. BMC Pregnancy Childbirth. 2022;22(1):392. [View at Publisher] [DOI] [PMID] [Google Scholar]
32. Said AS, Manji KP. Risk factors and outcomes of fetal macrosomia in a tertiary centre in Tanzania: a case-control study. BMC pregnancy and childbirth. 2016;16:1-8. [View at Publisher] [DOI] [PMID] [Google Scholar]
33. Clausen T, Burski T, Øyen N, Godang K, Bollerslev J, Henriksen T. Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study.Eur J Endocrinol. 2005;153(6):887-94. [View at Publisher] [DOI] [PMID] [Google Scholar]
34. Agudelo-Espitia V, Parra-Sosa BE, Restrepo-Mesa SL. Factors associated with fetal macrosomia. Rev Saude Publica. 2019;53:100. [View at Publisher] [DOI] [PMID] [Google Scholar]
35. Akindele R, Audu L, Mokuolu O. Macrosomic births in abuja: A case-control study of predisposing factors and early neonatal outcome. Niger J Clin Pract. 2017;20(3):320-7. [View at Publisher] [DOI] [PMID] [Google Scholar]
36. Kunasegaran T, Balasubramaniam VR, Arasoo VJT, Palanisamy UD, Ramadas A. Gestational diabetes mellitus in southeast Asia: A scoping review. Int J Environ Res Public Health. 2021;18(3):1272. [View at Publisher] [DOI] [PMID] [Google Scholar]
37. Atlaw D, Sahiledengle B, Assefa T, Negash W, Tahir A, Regasa T, et al. Incidence and risk factors of gestational diabetes mellitus in Goba town, Southeast Ethiopia: a prospective cohort study. BMJ Open. 2022;12(9):e060694. [View at Publisher] [DOI] [PMID] [Google Scholar]
38. Ghanghoriya V, Khan AP, Gupta K, Manhar R, Mandloi K. SCREENING OF ANTENATAL CASES IN SECOND TRIMESTER OF PREGNANCY FOR GESTATIONAL DIABETES MELLITUS. Int J Acad Med Pharm. 2023;5(5):330-4. [View at Publisher] [Google Scholar]
39. Salihu HM, Dongarwar D, King LM, Yusuf KK, Ibrahimi S, Salinas‐Miranda AA. Phenotypes of fetal macrosomia and risk of stillbirth among term deliveries over the previous four decades. Birth. 2020;47(2):202-10. [View at Publisher] [DOI] [PMID] [Google Scholar]
40. Barakat R, Pelaez M, Lopez C, Lucia A, Ruiz JR. Exercise during pregnancy and gestational diabetes-related adverse effects: a randomised controlled trial. Br J Sports Med. 2013;47(10):630-6. [View at Publisher] [DOI] [PMID] [Google Scholar]
41. Asemi Z, Samimi M, Tabassi Z, Esmaillzadeh A. The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial. Eur J Clin Nutr. 2014;68(4):490-5. [View at Publisher] [DOI] [PMID] [Google Scholar]
42. Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: a systematic review and meta-analysis. PloS One. 2014;9(3):e92485. [View at Publisher] [DOI] [PMID] [Google Scholar]
43. He X-J, Qin F-y, Hu C-L, Zhu M, Tian C-Q, Li L. Is gestational diabetes mellitus an independent risk factor for macrosomia: a meta-analysis? Archives of gynecology and obstetrics. 2015;291(4):729-35. [View at Publisher] [DOI] [PMID] [Google Scholar]
44. Yang G-R, Dye TD, Li D. Effects of pre-gestational diabetes mellitus and gestational diabetes mellitus on macrosomia and birth defects in Upstate New York. Diabetes Res Clin Pract. 2019;155:107811. [View at Publisher] [DOI] [PMID] [Google Scholar]
45. A. Lawlor D, Fraser A, Lindsay R, Ness A, Dabelea D, Catalano P, et al. Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort. Diabetologia. 2010;53(1):89-97. [View at Publisher] [DOI] [PMID] [Google Scholar]
46. Júnior EA, Peixoto AB, Zamarian ACP, Júnior JE, Tonni G. Macrosomia. Best Pract Res Clin Obstet Gynaecol. 2017;38:83-96. [View at Publisher] [DOI] [PMID] [Google Scholar]
47. Pereda J, Bove I, Pineyro MM. Excessive maternal weight and diabetes are risk factors for macrosomia: a cross-sectional study of 42,663 pregnancies in Uruguay. Front Endocrinol (Lausanne). 2020;11:588443. [View at Publisher] [DOI] [PMID] [Google Scholar]
48. Šegregur J, Buković D, Milinović D, Orešković S, Pavelić J, Župić T, Peršec J, et al. Fetal Macrosomia in Pregnant Women with Gestational Diabetes. Coll Antropol. 2009;33(4):1121-7. [View at Publisher] [Google Scholar]
49. Hay Jr WW. Placental-fetal glucose exchange and fetal glucose metabolism. Trans Am Clin Climatol Assoc. 2006;117:321-39. [View at Publisher] [PMID] [Google Scholar]
50. Gyurkovits Z, Kálló K, Bakki J, Katona M, Bitó T, Pál A, et al. Neonatal outcome of macrosomic infants: an analysis of a two-year period. Eur J Obstet Gynecol Reprod Biol. 2011;159(2):289-92. [View at Publisher] [DOI] [PMID] [Google Scholar]
51. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge A, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271-81. [View at Publisher] [DOI] [PMID] [Google Scholar]
52. Ekpor E, Akyirem S, Adade Duodu P. Prevalence and associated factors of overweight and obesity among persons with type 2 diabetes in Africa: a systematic review and meta-analysis. Ann Med. 2023;55(1):696-713. [View at Publisher] [DOI] [PMID] [Google Scholar]
53. Gaudet L, Ferraro ZM, Wen SW, Walker M. Maternal obesity and occurrence of fetal macrosomia: a systematic review and meta‐analysis. Biomed Res Int. 2014;2014(1):640291. [View at Publisher] [DOI] [PMID] [Google Scholar]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).